Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.555, 2008-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tamoxifen plus chemotherapy worth it in early breast cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. :
Access to resources
Recommend
Tamoxifen plus chemotherapy worth it in early breast cancer?
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :
Anastrozole: first-line therapy for advanced breast cancer?
Inpharma, Vol. 1, Iss. 1270, 2001-01 ,pp. :
Bisphosphonates: are they useful in breast cancer?
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
Improving uptake of breast cancer screening worth it in the US?
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :